Conjugated Polymers with Aggregation‐Induced Emission Characteristics for Fluorescence Imaging and Photodynamic Therapy

Lirong Wang,Rong Hu,Anjun Qin,Ben Zhong Tang
DOI: https://doi.org/10.1002/cmdc.202100138
IF: 3.54
2021-05-10
ChemMedChem
Abstract:Accurate diagnosis and treatment have been extensively developed in the field of biomedicine, which puts forward higher requirements for the development of biomedical materials with high efficiency and selectivity. Among them, aggregation‐induced emission (AIE) conjugated polymers have stood out in recent years owing to their unique properties, such as intense solid emission, high light‐harvesting ability, efficient energy transfer, and high 1 O 2 generation ability, which empower them effectively biomedical functions in fluorescence imaging (FL), photodynamic therapy (PDT), FL guided PDT, two‐photon excited photodynamic therapy (2PE‐PDT), etc . In this review, we highlight recent progress in AIE conjugated polymers and their applications in anticancer and antibacterial areas based on FL and PDT, and summarize the mechanism of color‐tuned fluorescent emission and efficient 1 O 2 generation ability compared with small molecular photosensitizer. Last but not least, the challenges and perspectives for the future development of AIE conjugated polymers are discussed.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?
The main problem this paper attempts to address is the development of efficient and highly selective biomedical materials, particularly the application of conjugated polymers with Aggregation-Induced Emission (AIE) characteristics in Fluorescence Imaging (FLI) and Photodynamic Therapy (PDT). Specifically, the paper focuses on the following aspects: 1. **Improving the efficiency of fluorescence imaging and photodynamic therapy**: By introducing AIE units and conjugated structures, these polymers can significantly enhance fluorescence intensity and quantum yield, thereby exhibiting higher sensitivity and better photostability in fluorescence imaging. Additionally, these polymers possess efficient singlet oxygen (1O2) generation capability, making them excellent in photodynamic therapy. 2. **Overcoming the limitations of traditional photosensitizers**: Traditional low-molecular-weight photosensitizers suffer from poor water solubility and photobleaching, limiting their clinical applications. AIE conjugated polymers address these issues by inhibiting non-radiative decay pathways, maintaining high fluorescence emission and ROS generation capabilities even in the aggregated state. 3. **Achieving multimodal imaging and therapy**: The paper explores how to utilize AIE conjugated polymers to achieve fluorescence imaging-guided photodynamic therapy (FLI-guided PDT) and two-photon excitation photodynamic therapy (2PE-PDT). These techniques enable precise tumor localization and continuous in vivo tracking, guiding doctors to perform light irradiation treatment at the appropriate time. 4. **Antibacterial applications**: In addition to anticancer applications, the paper also discusses the potential of AIE conjugated polymers in the antibacterial field. By designing AIE conjugated polymers with specific side chain structures, effective bacterial killing can be achieved, particularly for the treatment of antibiotic-resistant strains. In summary, this paper aims to systematically summarize the latest advancements in AIE conjugated polymers, showcasing their broad application prospects in the biomedical field, and proposing challenges and directions for future development.